What is Naltrexone?
Category: Prescription Drugs
Most popular types: Low Dose Naltrexone (LDN) Vivitrol ReVia
Naltrexone, in low doses such as 3mg to 4.5mg, has been found to boost the immune system in MS, autoimmune diseases, and central nervous system disorders.
Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Multiple sclerosis | 479 | 371 | |
Fibromyalgia | 204 | 272 | |
Fatigue | 153 | 197 | |
Pain | 57 | 65 | |
Myalgic encephalomyelitis/chronic fatigue syndrome | 46 | 96 | |
Amyotrophic lateral sclerosis | 42 | 39 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
Severity | Evaluations | Percentage |
---|---|---|
Severe | 48 | |
Moderate | 70 | |
Mild | 247 | |
None | 654 |
Why patients stopped taking Naltrexone
Multiple reasons could be selected
Reason | Patients | Percentage |
---|---|---|
Did not seem to work | 152 | |
Other | 71 | |
Side effects too severe | 55 | |
Doctor's advice | 43 | |
Expense | 20 | |
Personal research | 11 | |
Course of treatment ended | 10 | |
Change in health plan coverage | 3 |
Duration
Currently taking Naltrexone
Duration | Patients | Percentage |
---|---|---|
1 - 6 months | 1 | |
6 months - 1 year | 5 | |
1 - 2 years | 5 | |
2 - 5 years | 16 | |
5 - 10 years | 12 | |
10 years or more | 10 |
Stopped taking Naltrexone
Duration | Patients | Percentage |
---|---|---|
Less than 1 month | 44 | |
1 - 6 months | 91 | |
6 months - 1 year | 37 | |
1 - 2 years | 64 | |
2 - 5 years | 43 | |
5 - 10 years | 12 |
What people switch to and from
Patients started taking Naltrexone after stopping:
Treatment | Patients | Percentage |
---|---|---|
Lyrica) | Pregabalin (8 | |
Ultram) | Tramadol (8 | |
Neurontin) | Gabapentin (7 | |
Cymbalta) | Duloxetine (6 | |
Norco) | Hydrocodone-Acetaminophen (5 |
Patients stopped taking Naltrexone and switched to:
Treatment | Patients | Percentage |
---|---|---|
Tecfidera) | Dimethyl fumarate (2 | |
Campral) | Acamprosate (1 | |
Lemtrada) | Alemtuzumab (1 | |
Suboxone) | Buprenorphine-Naloxone (1 | |
Sinemet) | Carbidopa-Levodopa (1 |
Last updated: